Rathbones' Derber: We are in a multidecade transition to the cloud

6% of IT spent on cloud

clock • 5 min read

After the first on-premise databases and servers were introduced in the early 1980s, it took another 40 years for the growth in on-premise vendors to reach full maturity.

If the next platform shift follows a similar trajectory, our best guess is that we are only in the first or second inning of a multi-decade transition to the cloud. Given its ubiquity, you may find it surprising that companies have so far only redirected a small fraction of their IT budgets to the cloud. This offers investors one of the most compelling secular growth opportunities of the next decade. In 2020, only 6% of the $3.6trn spent globally on IT was spent on the cloud (about $220bn). When comparing that with the growth in US online spending as a percentage of total retail sales...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

While thematic funds offer diversification and a specialist knowledge base, investors must also consider the sensitivity to real bond yields inherent in these funds.

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
Deal volumes fell last year as rising interest rates brought the end of cheap money

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot